Covidien Demonstrates Breakthroughs in Minimally Invasive Surgery and Soft Tissue Repair at 2010 American College of Surgeons Congress

WASHINGTON--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will preview new devices and showcase some of the Company’s most innovative products at the 96th Annual Clinical Congress of the American College of Surgeons.
MORE ON THIS TOPIC